Corundum Open Innovation Fund (COIF I) LP

www.corundumoi.com

Venture Capital Fund

Fully invested

Tech Verticals Preferences

AgriTech, Artificial Intelligence, Big Data, Blockchain, Cloud, Cyber Security, Data Analytics, Digital Health, e-Commerce, Enterprise Applications, FinTech, Hardware, Healthtech, Industry 4.0, IoT, Medical Devices, MedTech, Mobile Applications, Mobility Tech, Robotics, Security

General Data

Management Company:	Corundum Open Innovation Ltd. (COIF)
Vintage Year	2016
Current Active Portfolio Companies:	5
Reg. Number:	abCDe

DESCRIPTION

Corundum Open Innovation is an Israel-Japan venture capital firm, backed by Japanese corporations, investing in top Israeli high-tech companies and top Israeli funds.
With teams in both Japan and Israel, Corundum provides quality access to the Israeli High-Tech Eco System and hands-on business development for investors and portfolio companies.

Related Funds

Fund Name	Fund Capital($m)	Status	Remarks
COIF II	abCDe	First Closing	Corundum Open Innovation Fund II (COIF II), invests in promising Israeli high-tech startups.

CONTACT INFO

Expand / Collapse All

Main Address: Herzliya, Israel

Address	11 Ha’Menofim St., Akerstein Towers B, 3rd Floor
City	Herzliya
Country	Israel
Zip	4672562

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Tokyo, Japan

Address	3-14-24 Hiroo, Shibuya-ku
City	Tokyo
Country	Japan
Zip	150-0012

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Mr. Gilad Peleg-Lorberbaum	Managing General Partner	Rainbow Medical (COO)

	CAPITAL RAISED

Date

Amount

Feb. 01, 2016

abCDe

Limited Partners	Type	Amount	Remarks
abC Defghij*	Holding Company	abCDe
abC Defghij	Other	abCDe

Investment Data

Capital Remarks	Investing in Information and Communications Technology & Life Sciences

Preferences

Type of Financing	Equity,Investments in Funds
Stage Preferences	Initial Revenues,R&D,Revenue Growth,Seed

SECTOR SEGMENTATION (By Number Of Companies)

Digital Health

50%

Medical Devices

50%

	PORTFOLIO COMPANIES

Current Portfolio Companies (5)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

270Surgical

Second Round	15/06/2020	N/A	N/A
First Round	01/11/2018	N/A	$13.5m

CathWorks

Dig. Health

Fourth Round	10/01/2021	N/A	$30m
Third Round	05/02/2019	N/A	$30m
Second Round	02/10/2017	$1m	$15.8m

Corundum Neuroscience

N/A

Investment in Fund

07/02/2017

N/A

$50m

Dario

Dig. Health

PIPE

23/08/2017

N/A

$5m

Nerivio

Theranica is a developer of electroceuticals, intended to address prevalent neurological pain diseases. The company's product offers an innovative FDA-authorized, non-invasive, smartphone-operated, prescribed wearable use-and-dispose, providing temporary or long-term pain relief, enabling patients to treat acute migraines in an affordable manner.

Third Round	29/08/2022	N/A	$45m
Second Round	18/03/2019	N/A	$33m
First Round	03/07/2017	N/A	$6m

Current VC Fund Portfolio (1)

Fund Name

Fund Type

Date Announced

Amount

Remarks

Vertex IV

Venture Capital Fund

11/05/2014

N/A

Exits (1)

Company Name		Exit Type	Date Announced	Amount	Remarks
abC Defghij		IPO	28/06/2018	abCDe

Last Updated:	abCDe
IVC Number:	abCDe